[1]
Habuka, M. et al. 2026. Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study. Journal of Clinical Medicine Research. 18, 11 (Jan. 2026), 815–822. DOI:https://doi.org/10.14740/jocmr6733.